Skip to main content
. 2022 Oct 19;5(10):e2237588. doi: 10.1001/jamanetworkopen.2022.37588

Table 1. Characteristics of the Study Population by Thrombocytopenia and Reception of Platelet Transfusion.

Characteristic Neonates, No./total No. (%)
Overall (N = 1221) By thrombocytopeniaa By platelet transfusion
With (n = 452) Without (n = 767) Received ≥1 (n = 94) Received 0 (n = 1127)
Sex
Male 731/1221 (59.9) 286/452 (63.3) 445/767 (58.0) 56/94 (59.6) 675/1127 (59.9)
Female 490/1221 (40.1) 166/452 (36.7) 322/767 (42.0) 38/94 (40.4) 452/1127 (40.1)
Weight at birth, g
Median (IQR) 1575.0 (1250.0-1940.0) 1300.0 (1060.0-1565.0) 1730.0 (1430.0-2112.0) 1060.0 (930.0-1290.0) 1600.0 (1305.0-1980.0)
Strata
<1000 95/1221 (7.8) 73/452 (16.2) 22/767 (2.9) 32/94 (34.0) 63/1127 (5.6)
1000-1499 442/1221 (36.2) 242/452 (53.5) 200/767 (26.1) 54/94 (57.4) 388/1127 (34.4)
1500-2499 610/1221 (50.0) 128/452 (28.3) 481/767 (62.71) 6/94 (6.4) 604/1127 (53.6)
2500-3999 74/1221 (6.1) 9/452 (2.0) 64/767 (8.3) 2/94 (2.1) 72/1127 (6.4)
Gestational age
Median (IQR), wk 31.0 (29.0-33.0) 30.0 (28.0-31.0) 31.0 (30.0-33.0) 28.0 (27.0-30.0) 31.0 (29.0-33.0)
Strata
<28 wk 0 d 103/1221 (8.4) 73/452 (16.2) 30/767 (3.9) 36/94 (38.3) 67/1127 (5.9)
28 wk 0 d to 31 wk 6 d 663/1221 (54.3) 282/452 (62.4) 381/767 (49.7) 52/94 (55.3) 611/1127 (54.2)
32 wk 0 d to 33 wk 6 d 283/1221 (23.2) 60/452 (13.3) 222/767 (28.9) 0/94 (0) 283/1127 (25.1)
34 wk 0 d to 36 wk 6 d 172/1221 (14.1) 37/452 (8.2) 134/767 (17.5) 6/94 (6.4) 166/1127 (14.7)
Congenital disorder 147/1221 (12.1) 62 (13.7) 85/767 (11.1) 20/94 (21.3) 127/1127 (11.3)
Singleton 990/1221 (81.1) 353 (78.1) 635/767 (82.8) 72/94 (76.6) 918/1127 (81.5)
Apgar score ≤7
1-min 316/1215 (26.0) 172/450 (38.2) 142/763 (18.6) 53/94 (56.4) 263/1121 (23.5)
5-min 123/1214 (10.1) 68/450 (15.1) 54/762 (7.1) 22/94 (23.4) 101/1120 (9.0)
10-min 69/1202 (5.7) 44/448 (9.8) 24/752 (3.2) 12/93 (12.9) 57/1109 (5.1)
Cesarean delivery 799/1221 (65.4) 297/452 (65.7) 500/767 (65.2) 52/94 (55.3) 747/1127 (66.3)
Maternal preeclampsia 183/1221 (15.0) 109/452 (24.1) 74/767 (9.6) 28/94 (29.8) 155/1127 (13.8)
Pregnancy-induced hypertension 50/1221 (4.1) 27/452 (6.0) 23/767 (3.0) 6/94 (6.4) 44/1127 (3.9)
Antenatal steroids given 745/1221 (61.6) 261/452 (58.1) 484/767 (63.7) 57/94 (62.0) 688/1127 (61.5)
Intrauterine distress 55/1221 (4.5) 32/452 (7.1) 23/767 (3.0) 5/94 (5.3) 50/1127 (4.4)
Maternal age, median (IQR), y 31.0 (28.0-35.0) 32.0 (28.0-35.0) 31.0 (28.0-35.0) 33.0 (29.0-36.0) 31.0 (28.0-35.0)
High-risk pregnancyb 290/1221 (23.8) 124/452 (27.4) 166/767 (21.6) 33/94 (35.1) 257/1127 (22.8)
Premature rupture of membrane 224/1221 (18.4) 49/452 (10.8) 175/767 (22.8) 3/94 (3.2) 221/1127 (19.6)
Ventilated later than birthday 70/1221 (5.7) 24/452 (5.3) 46/767 (6.0) 7/94 (7.4) 63/1127 (5.6)
Sepsisc 51/1221 (4.2) 38/452 (8.4) 13/767 (1.7) 16/94 (17.0) 35/1127 (3.1)
NECd 6/1221 (0.5) 2/452 (0.4) 4/767 (0.5) 1/94 (1.1) 5/1127 (0.4)
Length of hospital stay, median (IQR), d 35.0 (19.0-52.0) 48.0 (27.5-70.0) 28.0 (16.0-44.0) 66.5 (31.0-93.0) 33.0 (18.0-50.0)
Any grade of IVH 263/1221 (21.5) 156/452 (34.5) 107/767 (14.0) 50/94 (53.2) 213/1127 (18.9)
Grade 3 or 4 IVH 81/1221 (6.6) 61/452 (13.5) 20/767 (2.6) 26/94 (27.7) 55/1127 (4.9)
In-hospital mortality 80/1221 (6.6) 55/452 (12.2) 23/767 (3.0) 18/94 (19.2) 62/1127 (5.5)

Abbreviations: IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitis.

a

Thrombocytopenia was defined as any platelet count less than 150 × 103/μL during hospital stay. Results for 2 infants were missing because they did not receive any blood test during hospital stay. Percentages may not add to 100% due to rounding.

b

High-risk pregnancy was defined as maternal age less than 17 or greater than 35 years old.

c

Sepsis was defined by a positive blood culture.

d

NEC was defined as stage 2A or higher, according to modified Bell staging criteria.